CN105250995A - 增生性疤痕修复贴膜及其制备方法 - Google Patents
增生性疤痕修复贴膜及其制备方法 Download PDFInfo
- Publication number
- CN105250995A CN105250995A CN201510643630.5A CN201510643630A CN105250995A CN 105250995 A CN105250995 A CN 105250995A CN 201510643630 A CN201510643630 A CN 201510643630A CN 105250995 A CN105250995 A CN 105250995A
- Authority
- CN
- China
- Prior art keywords
- gamma interferon
- liposome
- sticky polymer
- scar
- permeation enhancers
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
- 231100000241 scar Toxicity 0.000 title claims abstract description 45
- 230000008439 repair process Effects 0.000 title claims abstract description 9
- 238000000034 method Methods 0.000 title claims abstract description 7
- 206010020718 hyperplasia Diseases 0.000 title abstract description 3
- 239000011505 plaster Substances 0.000 title abstract 4
- 230000002390 hyperplastic effect Effects 0.000 title abstract 2
- 229920000642 polymer Polymers 0.000 claims abstract description 75
- 102000008070 Interferon-gamma Human genes 0.000 claims description 101
- 108010074328 Interferon-gamma Proteins 0.000 claims description 101
- 229940044627 gamma-interferon Drugs 0.000 claims description 95
- 239000002502 liposome Substances 0.000 claims description 80
- 239000003623 enhancer Substances 0.000 claims description 43
- 239000007788 liquid Substances 0.000 claims description 38
- PEDCQBHIVMGVHV-UHFFFAOYSA-N Glycerine Chemical compound OCC(O)CO PEDCQBHIVMGVHV-UHFFFAOYSA-N 0.000 claims description 36
- IIZPXYDJLKNOIY-JXPKJXOSSA-N 1-palmitoyl-2-arachidonoyl-sn-glycero-3-phosphocholine Chemical compound CCCCCCCCCCCCCCCC(=O)OC[C@H](COP([O-])(=O)OCC[N+](C)(C)C)OC(=O)CCC\C=C/C\C=C/C\C=C/C\C=C/CCCCC IIZPXYDJLKNOIY-JXPKJXOSSA-N 0.000 claims description 26
- 210000000835 hypertrophic cicatrix Anatomy 0.000 claims description 26
- 229940067606 lecithin Drugs 0.000 claims description 26
- 239000000787 lecithin Substances 0.000 claims description 26
- 235000010445 lecithin Nutrition 0.000 claims description 26
- NRHMKIHPTBHXPF-TUJRSCDTSA-M sodium cholate Chemical compound [Na+].C([C@H]1C[C@H]2O)[C@H](O)CC[C@]1(C)[C@@H]1[C@@H]2[C@@H]2CC[C@H]([C@@H](CCC([O-])=O)C)[C@@]2(C)[C@@H](O)C1 NRHMKIHPTBHXPF-TUJRSCDTSA-M 0.000 claims description 25
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 claims description 24
- 239000002253 acid Substances 0.000 claims description 24
- 230000000694 effects Effects 0.000 claims description 24
- GTDHYNXLIKNVTJ-UHFFFAOYSA-N n-(1-hydroxy-2-methylpropan-2-yl)octadecanamide Chemical compound CCCCCCCCCCCCCCCCCC(=O)NC(C)(C)CO GTDHYNXLIKNVTJ-UHFFFAOYSA-N 0.000 claims description 24
- 150000004767 nitrides Chemical class 0.000 claims description 22
- 238000007789 sealing Methods 0.000 claims description 19
- 238000002360 preparation method Methods 0.000 claims description 13
- 238000001914 filtration Methods 0.000 claims description 12
- 238000004440 column chromatography Methods 0.000 claims description 9
- 102000004506 Blood Proteins Human genes 0.000 claims description 6
- 108010017384 Blood Proteins Proteins 0.000 claims description 6
- 230000006837 decompression Effects 0.000 claims description 6
- 239000003085 diluting agent Substances 0.000 claims description 6
- 229960003130 interferon gamma Drugs 0.000 claims description 6
- 239000012528 membrane Substances 0.000 claims description 6
- 239000004814 polyurethane Substances 0.000 claims description 6
- 229920002635 polyurethane Polymers 0.000 claims description 6
- 238000002390 rotary evaporation Methods 0.000 claims description 6
- 239000000725 suspension Substances 0.000 claims description 6
- 229920000058 polyacrylate Polymers 0.000 claims description 4
- 239000003814 drug Substances 0.000 abstract description 22
- 238000010521 absorption reaction Methods 0.000 abstract description 8
- 208000008454 Hyperhidrosis Diseases 0.000 abstract 1
- 238000002955 isolation Methods 0.000 abstract 1
- 239000003961 penetration enhancing agent Substances 0.000 abstract 1
- 239000012466 permeate Substances 0.000 abstract 1
- 231100000245 skin permeability Toxicity 0.000 abstract 1
- 208000013460 sweaty Diseases 0.000 abstract 1
- 210000000589 cicatrix Anatomy 0.000 description 13
- 229940079593 drug Drugs 0.000 description 8
- 102000014150 Interferons Human genes 0.000 description 6
- 108010050904 Interferons Proteins 0.000 description 6
- 230000000857 drug effect Effects 0.000 description 6
- 229940079322 interferon Drugs 0.000 description 6
- 108010025899 gelatin film Proteins 0.000 description 5
- 239000000203 mixture Substances 0.000 description 5
- 238000013270 controlled release Methods 0.000 description 4
- 210000001519 tissue Anatomy 0.000 description 4
- 230000008595 infiltration Effects 0.000 description 3
- 238000001764 infiltration Methods 0.000 description 3
- 238000002560 therapeutic procedure Methods 0.000 description 3
- 238000012795 verification Methods 0.000 description 3
- WCUXLLCKKVVCTQ-UHFFFAOYSA-M Potassium chloride Chemical compound [Cl-].[K+] WCUXLLCKKVVCTQ-UHFFFAOYSA-M 0.000 description 2
- FAPWRFPIFSIZLT-UHFFFAOYSA-M Sodium chloride Chemical compound [Na+].[Cl-] FAPWRFPIFSIZLT-UHFFFAOYSA-M 0.000 description 2
- 206010052428 Wound Diseases 0.000 description 2
- 208000027418 Wounds and injury Diseases 0.000 description 2
- 230000003213 activating effect Effects 0.000 description 2
- 230000002411 adverse Effects 0.000 description 2
- 230000000840 anti-viral effect Effects 0.000 description 2
- 210000004369 blood Anatomy 0.000 description 2
- 239000008280 blood Substances 0.000 description 2
- 230000024245 cell differentiation Effects 0.000 description 2
- 230000004663 cell proliferation Effects 0.000 description 2
- 238000006243 chemical reaction Methods 0.000 description 2
- 238000005516 engineering process Methods 0.000 description 2
- 230000036541 health Effects 0.000 description 2
- 230000001788 irregular Effects 0.000 description 2
- 239000011159 matrix material Substances 0.000 description 2
- 210000000822 natural killer cell Anatomy 0.000 description 2
- 238000005457 optimization Methods 0.000 description 2
- 239000011148 porous material Substances 0.000 description 2
- 239000011347 resin Substances 0.000 description 2
- 229920005989 resin Polymers 0.000 description 2
- 230000029663 wound healing Effects 0.000 description 2
- 206010006784 Burning sensation Diseases 0.000 description 1
- 208000001387 Causalgia Diseases 0.000 description 1
- 102000008186 Collagen Human genes 0.000 description 1
- 108010035532 Collagen Proteins 0.000 description 1
- 208000023890 Complex Regional Pain Syndromes Diseases 0.000 description 1
- 206010020751 Hypersensitivity Diseases 0.000 description 1
- 108060003951 Immunoglobulin Proteins 0.000 description 1
- 102000011782 Keratins Human genes 0.000 description 1
- 108010076876 Keratins Proteins 0.000 description 1
- 208000002193 Pain Diseases 0.000 description 1
- 208000003251 Pruritus Diseases 0.000 description 1
- 206010039203 Road traffic accident Diseases 0.000 description 1
- 210000001744 T-lymphocyte Anatomy 0.000 description 1
- 210000000447 Th1 cell Anatomy 0.000 description 1
- 210000004241 Th2 cell Anatomy 0.000 description 1
- 206010053615 Thermal burn Diseases 0.000 description 1
- 241000209140 Triticum Species 0.000 description 1
- 235000021307 Triticum Nutrition 0.000 description 1
- 230000002159 abnormal effect Effects 0.000 description 1
- 208000026935 allergic disease Diseases 0.000 description 1
- 230000007815 allergy Effects 0.000 description 1
- 230000000844 anti-bacterial effect Effects 0.000 description 1
- 230000003064 anti-oxidating effect Effects 0.000 description 1
- 239000003146 anticoagulant agent Substances 0.000 description 1
- 229940127219 anticoagulant drug Drugs 0.000 description 1
- 210000003719 b-lymphocyte Anatomy 0.000 description 1
- 230000009286 beneficial effect Effects 0.000 description 1
- 230000000975 bioactive effect Effects 0.000 description 1
- 230000015572 biosynthetic process Effects 0.000 description 1
- 210000004204 blood vessel Anatomy 0.000 description 1
- 230000037396 body weight Effects 0.000 description 1
- 238000004113 cell culture Methods 0.000 description 1
- 230000022534 cell killing Effects 0.000 description 1
- 230000011748 cell maturation Effects 0.000 description 1
- 229920001436 collagen Polymers 0.000 description 1
- 208000014439 complex regional pain syndrome type 2 Diseases 0.000 description 1
- 150000001875 compounds Chemical class 0.000 description 1
- 210000000736 corneocyte Anatomy 0.000 description 1
- 239000013078 crystal Substances 0.000 description 1
- 210000001151 cytotoxic T lymphocyte Anatomy 0.000 description 1
- 238000009792 diffusion process Methods 0.000 description 1
- 201000010099 disease Diseases 0.000 description 1
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 1
- BNIILDVGGAEEIG-UHFFFAOYSA-L disodium hydrogen phosphate Chemical compound [Na+].[Na+].OP([O-])([O-])=O BNIILDVGGAEEIG-UHFFFAOYSA-L 0.000 description 1
- 229910000397 disodium phosphate Inorganic materials 0.000 description 1
- 235000019800 disodium phosphate Nutrition 0.000 description 1
- 230000002500 effect on skin Effects 0.000 description 1
- 230000002708 enhancing effect Effects 0.000 description 1
- 210000000981 epithelium Anatomy 0.000 description 1
- 239000000835 fiber Substances 0.000 description 1
- 238000011010 flushing procedure Methods 0.000 description 1
- 239000007789 gas Substances 0.000 description 1
- 210000003714 granulocyte Anatomy 0.000 description 1
- 238000003306 harvesting Methods 0.000 description 1
- 239000008240 homogeneous mixture Substances 0.000 description 1
- 230000001969 hypertrophic effect Effects 0.000 description 1
- 102000018358 immunoglobulin Human genes 0.000 description 1
- 230000007365 immunoregulation Effects 0.000 description 1
- 239000004615 ingredient Substances 0.000 description 1
- 230000005764 inhibitory process Effects 0.000 description 1
- 208000028867 ischemia Diseases 0.000 description 1
- 230000002147 killing effect Effects 0.000 description 1
- 230000003902 lesion Effects 0.000 description 1
- 230000007774 longterm Effects 0.000 description 1
- 210000002540 macrophage Anatomy 0.000 description 1
- 239000000463 material Substances 0.000 description 1
- 230000004060 metabolic process Effects 0.000 description 1
- 210000004088 microvessel Anatomy 0.000 description 1
- 238000010369 molecular cloning Methods 0.000 description 1
- 229910000402 monopotassium phosphate Inorganic materials 0.000 description 1
- 235000019796 monopotassium phosphate Nutrition 0.000 description 1
- 230000003448 neutrophilic effect Effects 0.000 description 1
- 238000010606 normalization Methods 0.000 description 1
- 239000002674 ointment Substances 0.000 description 1
- 230000003647 oxidation Effects 0.000 description 1
- 238000007254 oxidation reaction Methods 0.000 description 1
- 230000001575 pathological effect Effects 0.000 description 1
- 230000035515 penetration Effects 0.000 description 1
- 239000008363 phosphate buffer Substances 0.000 description 1
- PJNZPQUBCPKICU-UHFFFAOYSA-N phosphoric acid;potassium Chemical group [K].OP(O)(O)=O PJNZPQUBCPKICU-UHFFFAOYSA-N 0.000 description 1
- 239000001103 potassium chloride Substances 0.000 description 1
- 235000011164 potassium chloride Nutrition 0.000 description 1
- 238000012913 prioritisation Methods 0.000 description 1
- 230000008569 process Effects 0.000 description 1
- 230000001737 promoting effect Effects 0.000 description 1
- 230000001681 protective effect Effects 0.000 description 1
- 238000011084 recovery Methods 0.000 description 1
- 238000007670 refining Methods 0.000 description 1
- 238000005067 remediation Methods 0.000 description 1
- 230000002000 scavenging effect Effects 0.000 description 1
- 230000028327 secretion Effects 0.000 description 1
- 230000035807 sensation Effects 0.000 description 1
- 238000009958 sewing Methods 0.000 description 1
- 239000011780 sodium chloride Substances 0.000 description 1
- 235000002639 sodium chloride Nutrition 0.000 description 1
- 239000002904 solvent Substances 0.000 description 1
- 239000000126 substance Substances 0.000 description 1
- 208000024891 symptom Diseases 0.000 description 1
- 230000008719 thickening Effects 0.000 description 1
- 230000000699 topical effect Effects 0.000 description 1
- 238000013271 transdermal drug delivery Methods 0.000 description 1
- 238000002054 transplantation Methods 0.000 description 1
- 210000003556 vascular endothelial cell Anatomy 0.000 description 1
- 230000024883 vasodilation Effects 0.000 description 1
- 230000002747 voluntary effect Effects 0.000 description 1
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 1
Landscapes
- Medicinal Preparation (AREA)
Abstract
Description
Claims (6)
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201510643630.5A CN105250995B (zh) | 2013-09-25 | 2013-09-25 | 增生性疤痕修复贴膜及其制备方法 |
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201510643630.5A CN105250995B (zh) | 2013-09-25 | 2013-09-25 | 增生性疤痕修复贴膜及其制备方法 |
CN201310439270.8A CN103495155B (zh) | 2013-09-25 | 2013-09-25 | 用于增生性疤痕修复的贴膜及其制备方法 |
Related Parent Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN201310439270.8A Division CN103495155B (zh) | 2013-09-25 | 2013-09-25 | 用于增生性疤痕修复的贴膜及其制备方法 |
Publications (2)
Publication Number | Publication Date |
---|---|
CN105250995A true CN105250995A (zh) | 2016-01-20 |
CN105250995B CN105250995B (zh) | 2018-06-22 |
Family
ID=49860474
Family Applications (3)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN201310439270.8A Active CN103495155B (zh) | 2013-09-25 | 2013-09-25 | 用于增生性疤痕修复的贴膜及其制备方法 |
CN201510643629.2A Active CN105213351B (zh) | 2013-09-25 | 2013-09-25 | 用于增生性疤痕修复的贴膜 |
CN201510643630.5A Active CN105250995B (zh) | 2013-09-25 | 2013-09-25 | 增生性疤痕修复贴膜及其制备方法 |
Family Applications Before (2)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN201310439270.8A Active CN103495155B (zh) | 2013-09-25 | 2013-09-25 | 用于增生性疤痕修复的贴膜及其制备方法 |
CN201510643629.2A Active CN105213351B (zh) | 2013-09-25 | 2013-09-25 | 用于增生性疤痕修复的贴膜 |
Country Status (1)
Country | Link |
---|---|
CN (3) | CN103495155B (zh) |
Cited By (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN106727115A (zh) * | 2016-12-13 | 2017-05-31 | 广东科玮生物技术股份有限公司 | 一种用于增生性疤痕修复的护肤霜及其制备方法 |
Families Citing this family (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN104983721A (zh) * | 2015-06-25 | 2015-10-21 | 河南行知专利服务有限公司 | 一种疤痕修复贴 |
CN107510884A (zh) * | 2017-09-30 | 2017-12-26 | 河南汇博医疗股份有限公司 | 一种硅凝胶弹性疤痕贴及其制备方法 |
EP4003256A4 (en) * | 2019-07-30 | 2023-05-24 | Kai P. Leung | LAYER COMPOSITION FOR THE TREATMENT AND PREVENTION OF SCARS |
Citations (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN2320230Y (zh) * | 1998-01-14 | 1999-05-26 | 上海东月医疗保健用品有限公司 | 祛疤硅凝胶膜 |
CN1491642A (zh) * | 2002-10-21 | 2004-04-28 | 马德林 | 贴膜剂及其制备方法 |
CN202105203U (zh) * | 2011-04-28 | 2012-01-11 | 上海市中医医院 | 一种用于皮肤病及溃疡创面的贴膜 |
CN103083282A (zh) * | 2011-11-03 | 2013-05-08 | 杭州炬九生物科技有限公司 | 一种新型水凝胶瘢痕贴及其制备工艺 |
CN103191460A (zh) * | 2013-04-15 | 2013-07-10 | 潘银根 | 壳聚糖硅酮敷料及其制备方法和用途 |
Family Cites Families (6)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US5318780A (en) * | 1991-10-30 | 1994-06-07 | Mediventures Inc. | Medical uses of in situ formed gels |
CN100425216C (zh) * | 2003-02-13 | 2008-10-15 | 上海东月医疗保健用品有限公司 | 充填式加强型疤痕贴的制备方法 |
JP5632577B2 (ja) * | 2005-01-31 | 2014-11-26 | 久光製薬株式会社 | 貼付剤 |
JP5248040B2 (ja) * | 2007-05-25 | 2013-07-31 | リードケミカル株式会社 | 5−メチル−1−フェニル−2−(1h)−ピリドン含有貼付剤 |
CN103127213A (zh) * | 2011-12-02 | 2013-06-05 | 贵州金玖生物技术有限公司 | 一种祛疤敷料 |
CN202724121U (zh) * | 2012-03-14 | 2013-02-13 | 南阳市汇博生物技术有限公司 | 剖腹产袪疤修复贴 |
-
2013
- 2013-09-25 CN CN201310439270.8A patent/CN103495155B/zh active Active
- 2013-09-25 CN CN201510643629.2A patent/CN105213351B/zh active Active
- 2013-09-25 CN CN201510643630.5A patent/CN105250995B/zh active Active
Patent Citations (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN2320230Y (zh) * | 1998-01-14 | 1999-05-26 | 上海东月医疗保健用品有限公司 | 祛疤硅凝胶膜 |
CN1491642A (zh) * | 2002-10-21 | 2004-04-28 | 马德林 | 贴膜剂及其制备方法 |
CN202105203U (zh) * | 2011-04-28 | 2012-01-11 | 上海市中医医院 | 一种用于皮肤病及溃疡创面的贴膜 |
CN103083282A (zh) * | 2011-11-03 | 2013-05-08 | 杭州炬九生物科技有限公司 | 一种新型水凝胶瘢痕贴及其制备工艺 |
CN103191460A (zh) * | 2013-04-15 | 2013-07-10 | 潘银根 | 壳聚糖硅酮敷料及其制备方法和用途 |
Cited By (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN106727115A (zh) * | 2016-12-13 | 2017-05-31 | 广东科玮生物技术股份有限公司 | 一种用于增生性疤痕修复的护肤霜及其制备方法 |
Also Published As
Publication number | Publication date |
---|---|
CN105213351B (zh) | 2018-03-13 |
CN105213351A (zh) | 2016-01-06 |
CN105250995B (zh) | 2018-06-22 |
CN103495155B (zh) | 2015-10-14 |
CN103495155A (zh) | 2014-01-08 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
Lima Júnior et al. | Pediatric burn treatment using tilapia skin as a xenograft for superficial partial-thickness wounds: a pilot study | |
Bing et al. | Randomized, multicenter, double‐blind, and placebo‐controlled trial using topical recombinant human acidic fibroblast growth factor for deep partial‐thickness burns and skin graft donor site | |
Voinchet et al. | Efficacy and safety of hyaluronic acid in the management of acute wounds | |
You et al. | Treatment of diabetic foot ulcers using cultured allogeneic keratinocytes—a pilot study | |
CN103495155B (zh) | 用于增生性疤痕修复的贴膜及其制备方法 | |
Hasatsri et al. | Randomized Clinical Trial of the Innovative Bilayered Wound Dressing Made of Silk and Gelatin: Safety and Efficacy Tests Using a Split‐Thickness Skin Graft Model | |
EP3484457B1 (en) | Topical formulation for promoting wound healing | |
Hamzah et al. | Keladi candik (Alocasia longiloba Miq.) petiole extracts promote wound healing in a full thickness excision wound model in rats | |
CN109700998A (zh) | 一种复方肌肤损伤再生修复剂及其制备方法 | |
Hasegawa et al. | Wound, pressure ulcer and burn guidelines–1: Guidelines for wounds in general | |
Kellar et al. | Improved wound closure rates and mechanical properties resembling native skin in murine diabetic wounds treated with a tropoelastin and collagen wound healing device | |
Rybka et al. | Biomedical Potential of Keratin-Biphalin Wound Dressing in Diabetic Mice: In Vitro and In Vivo Studies | |
Hao et al. | Dermlin and silver nanoparticles combined antibacterial dressing for skin wound repair | |
RU2657806C2 (ru) | Способ регионального лечения трофической язвы | |
Ahn et al. | A clinical study of micronized acellular dermal matrix collagen paste application with negative pressure wound therapy | |
Nie et al. | Cosmetic Improvement in Various Acute Skin Defects Treated With Tissue‐engineered Skin | |
CN112957519A (zh) | 用于制备促进创口愈合的水凝胶的组合物、水凝胶及其制备方法 | |
Nilforoushzadeh et al. | Treatment of superficial and deep partial width second degree burn's wound with allogeneic cord blood platelet gel | |
Pittella et al. | The use of bacterial nanocellulose as wound healing dressing: a scoping review | |
Farzamfar et al. | Diabetic foot ulcer | |
CN114452435B (zh) | 一种能够快速生效的高亲和液体敷料 | |
Bryan | Evaluation of Magnesium and Elastin Incorporation into Electrospun Chitosan Membranes for Skin Wounds | |
US20230310552A1 (en) | Biomimetic wound healing devices and related methods of treating diabetic wounds | |
WOUND | E-POSTER SESSION: ANTIMICROBIALS | |
Rosselle | Development of biological models to test new treatments for chronic and infected wounds |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
C06 | Publication | ||
PB01 | Publication | ||
C10 | Entry into substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
CB02 | Change of applicant information |
Address after: 473000 middle section of Wei ten road, new energy economic and Technological Development Zone, Nanyang, Henan Applicant after: Henan Huibo Medical Co.,Ltd. Address before: 473000 Wei three road, Lihe eco industrial park, Nanyang, Henan Applicant before: Nanyang Huibo Biotechnology Co.,Ltd. |
|
CB02 | Change of applicant information | ||
GR01 | Patent grant | ||
GR01 | Patent grant | ||
PE01 | Entry into force of the registration of the contract for pledge of patent right |
Denomination of invention: Hyperplastic scar repair film and its preparation Effective date of registration: 20201221 Granted publication date: 20180622 Pledgee: China Construction Bank Nanyang Branch Pledgor: Henan Huibo Medical Co.,Ltd. Registration number: Y2020990001466 |
|
PE01 | Entry into force of the registration of the contract for pledge of patent right | ||
PC01 | Cancellation of the registration of the contract for pledge of patent right |
Date of cancellation: 20221209 Granted publication date: 20180622 Pledgee: China Construction Bank Nanyang Branch Pledgor: Henan Huibo Medical Co.,Ltd. Registration number: Y2020990001466 |
|
PC01 | Cancellation of the registration of the contract for pledge of patent right | ||
PE01 | Entry into force of the registration of the contract for pledge of patent right |
Denomination of invention: Hypertrophic scar repair mask and its preparation method Effective date of registration: 20221227 Granted publication date: 20180622 Pledgee: China Construction Bank Nanyang Branch Pledgor: Henan Huibo Medical Co.,Ltd. Registration number: Y2022980029245 |
|
PE01 | Entry into force of the registration of the contract for pledge of patent right |